2m 2m 2m 2m 2m 2m 2m
Lexaria Bioscien (LEXX)
NASDAQ
$0.63+$0.01 (+2.32%)
Price as of Jun 03, 2026 4:36 PM EDT- $14.9MMarket Cap
- -35.52%1-Year Change
- BiotechnologyIndustry
Lexaria Bioscien (LEXX)
$0.63+$0.01 (+2.32%)
Annual
Quarterly
08/31/2025 | 08/31/2024 | 08/31/2023 | 08/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 705,923 +52.05% | 464,278 +105.24% | 226,208 -11.43% | 255,397 -64.66% | |
Cost of Revenue | 2,720 -43.59% | 4,822 -84.69% | 31,500 -56.15% | 71,841 -59.03% | |
Gross Profit | 703,203 +53.05% | 459,456 +135.97% | 194,708 +6.08% | 183,556 -66.47% | |
Sales and Marketing Expense | 408,367 N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -8.2M +249.02% | -2.4M -35.62% | -3.7M +98.99% | -1.8M +45.91% | |
Depreciation and Amortization Expense | 87,825 +15.33% | 76,153 -47.62% | 145,397 +41.55% | 102,718 -8.06% | |
Total Operating Expenses | 12.6M +102.56% | 6.2M -7.67% | 6.7M -11.08% | 7.6M +21.38% | |
Operating Profit | -11.9M +106.51% | -5.8M -11.95% | -6.5M -11.51% | -7.4M +76.38% | |
Interest Income | 3,017 -78.63% | 14,117 -67.31% | 43,190 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 3,017 -78.63% | 14,117 -67.31% | 43,190 N/A | 0 N/A | |
Total Nonoperating Income and Expense | -30,697 -44.71% | -55,524 -68.89% | -178,503 N/A | N/A N/A | |
Income before Taxes | -11.9M +106.51% | -5.8M -11.95% | -6.5M -10.12% | -7.3M +80.51% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.9M +105.37% | -5.8M -13.05% | -6.7M -8.31% | -7.3M +73.65% | |
Net Income from Continuing Operations Applicable to Common | -11.9M +105.37% | -5.8M -13.05% | -6.7M -8.31% | -7.3M +27.83% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.66 +40.43% | -0.47 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 18.0M +45.34% | 12.4M +87.24% | 6.6M +12.38% | 5.9M +34.02% | |
Diluted Weighted Average Shares | 18.0M +45.34% | 12.4M N/A | N/A N/A | 5.9M +34.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.8M -72.27% | 6.5M +380.72% | 1.4M -76.74% | 5.8M -46.75% | |
Short-Term Investments | 22,093 -60.41% | 55,807 -55.58% | 125,642 -63.83% | 347,335 -58.35% | |
Cash and Cash Equivalents and Short-Term Investments | 1.8M -72.17% | 6.6M +343.63% | 1.5M -76.01% | 6.2M -47.58% | |
Total Current Assets | 3.5M -56.09% | 7.9M +259.04% | 2.2M -68.47% | 7.0M -43.92% | |
Accumulated Depreciation | 259,981 -49.77% | 517,616 +8.93% | 475,168 +25.05% | 379,993 +36.64% | |
Property and Plant and Equipment and Net | 228,129 -10.44% | 254,709 +0.22% | 254,143 -19.45% | 315,505 -57.16% | |
Total Long-Term Assets | 706,776 -27.12% | 969,803 +9.68% | 884,214 +3.25% | 856,411 +3.95% | |
Total Assets | 4.2M -52.92% | 8.9M +187.54% | 3.1M -60.63% | 7.8M -40.95% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 1.5M +35.84% | 1.1M +310.64% | 267,735 +37.98% | 194,036 +26.59% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 78,903 N/A | N/A N/A | N/A N/A | 7,401 -85.19% | |
Total Liabilities | 1.6M +30.08% | 1.2M +199.26% | 403,908 +100.51% | 201,437 -0.90% | |
Retained Earnings | -63.5M +23.08% | -51.6M +12.66% | -45.8M +17.05% | -39.1M +22.84% | |
Total Stockholders Equity | 3.0M -62.80% | 8.0M +164.00% | 3.0M -61.70% | 7.9M -40.08% | |
Total Shares Outstanding | 19.6M +23.71% | 15.8M +95.39% | 8.1M +35.97% | 6.0M +3.92% | |
Cash Flow | |||||
Cash from Operating Activities | -10.5M +110.74% | -5.0M -15.68% | -5.9M +20.53% | -4.9M +22.30% | |
Capital Expenditures | 24,646 -42.70% | 43,014 +27.46% | 33,748 N/A | N/A N/A | |
Cash from Investing Activities | -243,019 +28.85% | -188,605 +11.20% | -169,610 -6.11% | -180,640 -193.17% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.0M N/A | N/A N/A | 1.6M +3,664.42% | -44,600 -100.33% | |
Financials Ratio | |||||
Gross Margin | 99.61% +0.66% | 98.96% +14.97% | 86.07% +19.76% | 71.87% -5.11% | |
Operating Margin | -1,683.01% +35.82% | -1,239.16% -57.10% | -2,888.50% -0.09% | -2,891.05% +399.14% | |
Return on Assets | -182.50% +88.19% | -96.98% -20.57% | -122.09% +77.20% | -68.90% +32.46% | |
Return on Equity | -215.88% +106.38% | -104.60% -13.73% | -121.26% +76.94% | -68.53% +29.26% | |
Revenue Growth | 52.05% -50.55% | 105.24% +1,020.86% | -11.43% -82.33% | -64.66% -173.52% | |
Current Ratio | 2.32 -67.67% | 7.18 -12.57% | 8.22 -77.15% | 35.96 -55.70% | |
Cash Ratio | 1.21 -79.59% | 5.91 +17.07% | 5.05 -83.14% | 29.96 -57.94% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow